TMC Life Sciences Bhd
KLSE:TMCLIFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/FCFE
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.
Valuation Scenarios
If P/FCFE returns to its 3-Year Average (24.4), the stock would be worth MYR-0.37 (174% downside from current price).
| Scenario | P/FCFE Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -32.9 | MYR0.5 |
0%
|
| 3-Year Average | 24.4 | MYR-0.37 |
-174%
|
| 5-Year Average | 28.5 | MYR-0.43 |
-186%
|
| Industry Average | 13.7 | MYR-0.21 |
-142%
|
| Country Average | 16.5 | MYR-0.25 |
-150%
|
Forward P/FCFE
Today’s price vs future free cash flow to equity
Peer Comparison
| Market Cap | P/FCFE | P/E | ||||
|---|---|---|---|---|---|---|
| MY |
T
|
TMC Life Sciences Bhd
KLSE:TMCLIFE
|
870.9m MYR | -32.9 | 69.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
104.3B USD | 12.3 | 59 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
72.9B EUR | 12.6 | 14.1 | |
| US |
|
Cigna Corp
NYSE:CI
|
74.5B USD | 0 | 12.5 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.2B EUR | -25.1 | 18.4 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
22.4B EUR | 13.9 | 22.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.4B USD | 23.7 | 21 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21B USD | 627.8 | 24 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.8B EUR | 6.7 | 11 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.4B USD | 69.1 | -27.5 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 6 | 13.9 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 10.7 |
| Median | 16.5 |
| 70th Percentile | 31.5 |
| Max | 143 415.1 |
Other Multiples
TMC Life Sciences Bhd
Glance View
TMC Life Sciences Bhd.operates as an investment holding company. The company is headquartered in Petaling Jaya, Selangor and currently employs 1,108 full-time employees. The company went IPO on 2005-10-06. The firm's subsidiaries include IVF Technologies Sdn. Bhd., which is a provision of fertility services and operation of women’s clinic; TMC Biotech Sdn. Bhd., which is a provision of fertility consultancy, laboratory and embryology services and research and development; TMC Lifestyle Sdn. Bhd., which is developing, marketing and management of healthcare programs; TMC Properties Sdn. Bhd., which is a property investment; Thomson TCM Sdn. Bhd., which is a provides traditional and complementary services; BB Waterfront Sdn. Bhd., which provides healthcare services, TMC Women’s Specialist Holdings Sdn. Bhd., which is in the business of operating fertility centers and providing related services, and TMC Care Sdn. Bhd., which is engaged in the provision of pharmacy services and products, and management support services.
